New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cannara Biotech Inc.
LOVFF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

42M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Dec 2024

42M

Drug Manufacturers - Specialty & Generic

Next Earning date - 05 Dec 2024

0.47USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

58%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

40%

Quote Panel

Shape
Updated October 24, 2024
1W -2.25 % 1M 17.25 % 3M 13.56 % 1Y -34.43 %

Key Metrics

Shape
  • Market Cap

    41.91M


  • Shares Outstanding

    90.02M


  • Share in Float

    43.80M


  • Dividende

    0


  • Earning Date

    05 Dec 2024


  • Price Target

    0.4656


  • Average Volume

    1402


  • Beta

    1.082


  • Range

    0.387-0.775


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://cannara.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.77x

P/S Ratio

0.73x

P/B Ratio

0.6

Debt/Equity

6.9%

Net Margin

$0.0

EPS

How LOVFF compares to sector?

P/E Ratio

Relative Strength

Shape

LOVFF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

NA
vs -0.01

Q2.22

arrow
arrow

+17%

0.02
vs 0.02

Q3.22

arrow
arrow

N/A

NA
vs 0.01

Q4.22

arrow
arrow

N/A

NA
vs -0.00

Q1.23

arrow
arrow

N/A

-0.01
vs NA

Q2.23

arrow
arrow

+71%

0.04
vs 0.02

Q3.23

arrow
arrow

N/A

NA
vs NA

Q4.23

arrow
arrow

N/A

0.02
vs NA

Q1.24

arrow
arrow

N/A

-0.03
vs -0.01

Q2.24

arrow
arrow

-100%

NA
vs 0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+229%

7.4M  vs 2.3M

Q2.22

arrow
arrow

+41%

10.1M  vs 7.2M

Q3.22

arrow
arrow

+89%

11.8M  vs 6.2M

Q4.22

arrow
arrow

+57%

10.3M  vs 6.6M

Q1.23

arrow
arrow

+76%

13M  vs 7.4M

Q2.23

arrow
arrow

+57%

15.8M  vs 10.1M

Q3.23

arrow
arrow

+55%

18.3M  vs 11.8M

Q4.23

arrow
arrow

+89%

19.5M  vs 10.3M

Q1.24

arrow
arrow

+51%

19.7M  vs 13M

Q2.24

arrow
arrow

+23%

19.5M  vs 15.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.02

Q4.22

arrow
arrow

+0%

0
vs 0.04

Q1.23

arrow
arrow

-1%

-0.01
vs 0

Q2.23

arrow
arrow

+4%

0.04
vs -0.01

Q3.23

arrow
arrow

+6%

0.06
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.06

Q1.24

arrow
arrow

-4%

-0.04
vs 0.03

Q2.24

arrow
arrow

+2%

0.02
vs -0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News